Page 7 - Clinj Am Soc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in Dialysis

Fresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in Dialysis
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Scott sayresPat mccarthyOnline technologyExchange commissionTm blood chamberFresenius medical care ag coRenal therapies groupCorporate communicationsFresenius medical care holdings incLine blood chamberFresenius medical careOffers innovative new designFresenius medical care north americaMike angerChief medical officerMedical care north america

Kapruvia® approved by European Commission for the treatment

First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patientsFirst launches in Europe.

Vifor pharmaIris francesconiKlaus henning jensenAnnie spinettaNathalie ponnierJoana goncalvesSwiss stock exchangeEuropean commissionDrug administrationGlobal head corporate communicationsSwiss exchangeInternational journal of nephrologyExchange commissionCara therapeutics incVifor pharma groupEuropean union

Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Vifor pharmaIris francesconiKlaus henning jensenAnnie spinettaNathalie ponnierJoana goncalvesInternational journal of nephrologyCara therapeutics incVifor pharma groupEuropean unionNational registry studySwiss stock exchangeDrug administrationEuropean commissionGlobal head corporate communicationsSwiss exchange

Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients

Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Vifor pharmaIris francesconiKlaus henning jensenAnnie spinettaNathalie ponnierJoana goncalvesInternational journal of nephrologyCara therapeutics incVifor pharma groupEuropean unionNational registry studySwiss stock exchangeDrug administrationEuropean commissionGlobal head corporate communicationsSwiss exchange

Natera Validates Prospera™ With Quantification in Multi-Site, Prospective Trifecta Study

/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing, today announced the initial results1 from the global, multi-site,.

United statesSan carlosBernie tobinMike brophyKate stabrawaPhil halloranNatera incClinical laboratory improvement amendmentsAlberta transplant applied genomics centreDrug administrationAlberta transplant applied genomicsImmune quiescence gene expression signatureBlood gene expressionDiagnose subclinical rejectionKidney transplantClinj am soc